Regulatory Network in Protein Phosphorylation
[Home] [About] [Browse Kinome] [Phosphorylation Prediction] [Expression Analysis] [Statistics] [Help] Version 1.0

[Back to Kinase ABL2(ARG)]
Substrate: JUN

Description: Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogenec-jun) (V-jun avian sarcoma virus 17 oncogene homolog) (p39).

Ensembl ID: ENSG00000177606

UniprotKB/SwissProt: JUN_HUMAN (P05412)

Function: Transcription factor that recognizes and binds to the enhancer heptamer motif 5'-TGA[CG]TCA-3'.

Other Modifications: View all modification sites in dbPTM

Protein Subcellular Localization: Nucleus.
Protein Domain and Phosphorylation Sites:

The phosphorylated sites of JUN

No.SubstrateUniProtKB IDPositionPhosphoPeptideSolvent AccessibilityCatalytic kinaseSourceComputational Annotation of Catalytic KinaseInteracting PartnersExpression Analysis
1JUNJUN_HUMANS63SDLLT S PDVGL 21.05%JNK1(MAPK8) Swiss-Prot 55.0  ViewAnalyzing
2JUNJUN_HUMANS63SDLLT S PDVGL 21.05%JNK1 HPRD:01302(in vivo)  ViewAnalyzing
3JUNJUN_HUMANS63SDLLT S PDVGL 21.05%VRK1 Phospho.ELM 7.0  ViewAnalyzing
4JUNJUN_HUMANS63SDLLT S PDVGL 21.05%JNK1(MAPK8) Phospho.ELM 7.0 ViewAnalyzing
5JUNJUN_HUMANS63SDLLT S PDVGL 21.05%JNK2(MAPK9) Phospho.ELM 7.0 ViewAnalyzing
6JUNJUN_HUMANS63SDLLT S PDVGL 21.05%CK2_group Phospho.ELM 7.0 ViewAnalyzing
7JUNJUN_HUMANS63SDLLT S PDVGL 21.05%CDK_group Phospho.ELM 7.0 ViewAnalyzing
8JUNJUN_HUMANS73LLKLA S PELER 29.37%CDK_group Phospho.ELM 7.0 ViewAnalyzing
9JUNJUN_HUMANS73LLKLA S PELER 29.37%JNK1 HPRD:01302(in vivo)  ViewAnalyzing
10JUNJUN_HUMANS73LLKLA S PELER 29.37%JNK1(MAPK8) Swiss-Prot 55.0  ViewAnalyzing
11JUNJUN_HUMANS73LLKLA S PELER 29.37%VRK1 Phospho.ELM 7.0  ViewAnalyzing
12JUNJUN_HUMANS73LLKLA S PELER 29.37%CK2_group Phospho.ELM 7.0 ViewAnalyzing
13JUNJUN_HUMANS73LLKLA S PELER 29.37%JNK1(MAPK8) Phospho.ELM 7.0 ViewAnalyzing
14JUNJUN_HUMANT91GHITT T PTPTQ 19.26% Phospho.ELM 7.0View   
15JUNJUN_HUMANT93ITTTP T PTQFL 36.55% Phospho.ELM 7.0View   
16JUNJUN_HUMANY170SEPPV Y ANLSN 8.78% HPRD:01302(in vivo)View   
17JUNJUN_HUMANY170SEPPV Y ANLSN 8.78% Phospho.ELM 7.0View   
18JUNJUN_HUMANY170SEPPV Y ANLSN 8.78%ABL1 HPRD:01302(in vitro;in vivo)  ViewAnalyzing
19JUNJUN_HUMANT231KEEPQ T VPEMP 49.06%CK2a1-rs HPRD:01302(in vitro;in vivo)  ViewAnalyzing
20JUNJUN_HUMANT231KEEPQ T VPEMP 49.06%CK2a1(CK2 alpha) Phospho.ELM 7.0 ViewAnalyzing
21JUNJUN_HUMANT231KEEPQ T VPEMP 49.06%CK2_group Phospho.ELM 7.0 ViewAnalyzing
22JUNJUN_HUMANT231KEEPQ T VPEMP 49.06%CK2a1 HPRD:01302(in vitro;in vivo)  ViewAnalyzing
23JUNJUN_HUMANT239EMPGE T PPLSP 35.80%GSK3A(GSK3 alpha) Phospho.ELM 7.0 ViewAnalyzing
24JUNJUN_HUMANT239EMPGE T PPLSP 35.80%GSK_group Phospho.ELM 7.0 ViewAnalyzing
25JUNJUN_HUMANS243ETPPL S PIDME 26.11%GSK3A(GSK3 alpha) Phospho.ELM 7.0 ViewAnalyzing
26JUNJUN_HUMANS243ETPPL S PIDME 26.11%CK2a1(CK2 alpha) Phospho.ELM 7.0 ViewAnalyzing
27JUNJUN_HUMANS249PIDME S QERIK 30.61%DNAPK Phospho.ELM 7.0  ViewAnalyzing
28JUNJUN_HUMANS249PIDME S QERIK 30.61%CK2_group Phospho.ELM 7.0 ViewAnalyzing
29JUNJUN_HUMANS249PIDME S QERIK 30.61%CK2a1(CK2 alpha) Phospho.ELM 7.0 ViewAnalyzing
30JUNJUN_HUMANS249PIDME S QERIK 30.61%CK2a1-rs HPRD:01302(in vitro;in vivo)  ViewAnalyzing
31JUNJUN_HUMANS249PIDME S QERIK 30.61%CK2a1 HPRD:01302(in vitro;in vivo)  ViewAnalyzing
32JUNJUN_HUMANS249PIDME S QERIK 30.61%DNAPK HPRD:01302(in vitro)  ViewAnalyzing